Sexual dysfunction in HIV-infected men: Role of antiretroviral therapy, hypogonadism and lipodystrophy

Antiviral Therapy

Volumn 12, Issue 7, 2007, Pages 1059-1066

  Guaraldi, Giovanni ^a   Luzi, Kety ^a   Murri, Rita ^b   Granata, Antonio ^a   De Paola, Maria ^a   Orlando, Gabriella ^a   Squillace, Nicola ^a   Malmusi, Davide ^c   Carani, Cesare ^a   Comelli, Dante ^d   Esposito, Roberto ^a   Martinez, Esteban ^e  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c Del Mar University   (Spain)

^d UNIVERSITY OF PARMA   (Italy)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; STAVUDINE; TESTOSTERONE; ZIDOVUDINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY IMAGE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HABIT; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MENTAL HEALTH; ORGASM; OUTCOME ASSESSMENT; PLASMA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REGRESSION ANALYSIS; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SOCIAL LIFE; TESTOSTERONE BLOOD LEVEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY IMAGE; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 36148951368     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281:537-544.
2. Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR. A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS 2005; 19:655-671.
3. Collazos J, Martinez E, Mayo J, Ibarra S. Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:322-326.
4. Schrooten W, Colebunders R, Youle M, et al. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS 2001; 15:1019-1023.
5. Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002; 30:187-190.
6. Collazos J, Mayo J, Martinez E, Ibarra S. Association between sexual disturbances and sexual hormones with specific antiretroviral drugs. AIDS 2002; 16:1294-1295.
7. Colebunders R, Smets E, Verdonck K, Dreezen C. Sexual dysfunction with protease inhibitors. Lancet 1999; 353:1802.
8. Sollima S, Osio M, Muscia F, et al. Protease inhibitors and erectile dysfunction. AIDS 2001; 15:2331-2333.
9. Ende AR, Lo Re V 3rd, DiNubile MJ, Mounzer K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS 2006; 20:75-78.
10. Beutel ME, Weidner W, Brahler E. Epidemiology of sexual dysfunction in the male population. Andrologia 2006; 38:115-121.
11. Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet 2007; 369:409-424.
12. Colson AE, Keller MJ, Sax PE, Pettus PT, Platt R, Choo PW. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 30:27-32.
13. Collazos J, Martinez E, Mayo J, Ibarra S. Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy. AIDS 2002; 16:934-937.
14. Murri R, Fantoni M, Del Borgo C, et al. Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life. J Acquir Immune Defic Syndr 2003; 34:532-534.
15. Richardson D, Lamba H, Goldmeier D, Nalabanda A, Harris JR. Factors associated with sexual dysfunction in men with HIV infection. Int J STD AIDS 2006; 17:764-767.
16. Guaraldi G, Orlando G, Squillace N, et al. Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy. HIV Clin Trials 2006; 7:97-106.
17. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91:1995-2010.
18. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 2005; 48:1-4.
19. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001; 15:1389-1398.
20. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49:822-830.
21. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14:226-244.
22. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54:346-351.
23. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care 1991; 29:786-798.
24. Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36:126-137.
25. Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:350-356.
26. Guaraldi G, Orlando G, Murri R, et al. Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the Italian version of assessment of body change and distress questionnaire. Qual Life Res 2006; 15:173-178.
27. Basson R. Sexuality in chronic illness: no longer ignored. Lancet 2007; 369:350-352.
28. Wagner GJ, Rabkin JG. Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS. Int J STD AIDS 1998; 9:41-44.
29. Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 2000; 31:1240-1244.
30. Goldmeier D, Lamba H. Sexual dysfunction in HIV-positive individuals. Int J STD AIDS 2003; 14:63-64.
31. Grinspoon S. Androgen deficiency and HIV infection. Clin Infect Dis 2005; 41:1804-1805.
32. Carani C, Granata AR, Fustini MF, Marrama P. Prolactin and testosterone: their role in male sexual function. Int J Androl 1996; 19:48-54.
33. Granata AR, Rochira V, Lerchl A, Marrama P, Carani C. Relationship between sleep-related erections and testosterone levels in men. J Androl 1997; 18:522-527.
34. Lamba H, Goldmeier D, Mackie NE, Scullard G. Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. Int J STD AIDS 2004; 15:234-237.
35. Catalan J, Meadows J. Sexual dysfunction in gay and bisexual men with HIV infection: evaluation, treatment and implications. AIDS Care 2000; 12:279-286.
36. Jones M, Klimes I, Catalan J. Psychosexual problems in people with HIV infection: controlled study of gay men and men with haemophilia. AIDS Care 1994; 6:587-593.
37. Kratzik CW, Schatzl G, Lunglmayr G, Rucklinger E, Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 2005; 174:240-243.